Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Calliditas Therapeutics Q1 EPS $(0.88) Down From $(0.33) YoY, Sales $28.43M Up From $18.32M YoY

Author: Benzinga Newsdesk | May 23, 2024 02:06am

Calliditas Therapeutics (NASDAQ:CALT) reported quarterly losses of $(0.88) per share. This is a 163.47 percent decrease over losses of $(0.33) per share from the same period last year. The company reported $28.43 million in sales this quarter. This is a 55.21 percent increase over sales of $18.32 million the same period last year.

Posted In: CALT